Cumberland Pharmaceuticals (CPIX) Equity Ratio (2010 - 2026)

Cumberland Pharmaceuticals has disclosed Equity Ratio across 17 years of filings, most recently posting 0.3 for Q1 2026.

• Equity Ratio for Q1 2026 came in at 0.3, down 25.95% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.3 (down 25.95% YoY), and the FY2025 annual result was 0.32, up 8.57% from the prior year.
• Equity Ratio came in at 0.3 for Q1 2026 at Cumberland Pharmaceuticals, down from 0.32 in the prior quarter.
• In the past five years, Equity Ratio ranged from a high of 0.43 in Q3 2022 to a low of 0.3 in Q4 2024.
• The 5-year median for Equity Ratio is 0.39 (2025), against an average of 0.37.
• Across the five-year window, Equity Ratio rose 22.94% in 2025 and slipped 25.95% in 2026, its largest moves.
• Cumberland Pharmaceuticals' Equity Ratio stood at 0.39 in 2022, then retreated by 7.57% to 0.36 in 2023, then retreated by 16.63% to 0.3 in 2024, then climbed by 8.57% to 0.32 in 2025, then slipped by 7.35% to 0.3 in 2026.
• The last three Equity Ratio figures came in at 0.3 (Q1 2026), 0.32 (Q4 2025), and 0.39 (Q3 2025), per Business Quant data.